Mustang Stock Financials

MBIO
 Stock
  

USD 0.52  0.03  6.12%   

Mustang Bio Enterprise Value is quite stable at the moment as compared to the past year. The company's current Enterprise Value is estimated at 36.23 Million. Invested Capital is expected to rise to about 7.9 M this year, although the value of Net Income Per Employee will most likely fall to (702.1 K).
  
With this module, you can analyze Mustang financials for your investing period. You should be able to track the changes in Mustang Bio individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.

Mustang Most Recent Estimates

EPS Estimate Next Quarter
(0.19) 
Diluted Eps
(0.77) 
EPS Estimate Current Year
(0.75) 
EPS Estimate Next Year
(0.67) 
EPS Estimate Current Quarter
(0.20) 
Earnings Share
(0.77) 
Understanding current and past Mustang Bio Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Mustang Bio's financial statements are interrelated, with each one affecting the others. For example, an increase in Mustang Bio's assets may result in an increase in income on the income statement.

Total Debt

2.09 Million

The financial analysis of Mustang Bio is a critical element in measuring its lifeblood. The essential information of the day-to-day investment outlook for Mustang Bio includes many different criteria found on its balance sheet. For example, investors should never minimize Mustang Bio's ability to pay suppliers or employees on time, making sure interest payments are not accumulating or correctly timing where and how to re-invest extra cash. Any individual investor needs to monitor Mustang Bio's cash flow, debt, and profitability to effectively and accurately make more informed decisions on whether to invest in Mustang Bio.

Mustang Bio Cash

Chance Of Financial Distress
Over 94
Mustang Bio has more than 94 (%) percent chance of experiencing financial distress in the next two years of operations. The calculation of odds of distress for Mustang Bio stock is tightly coupled with the Probability of Bankruptcy. It complements the equity performance score by supplying investors with insight into company financials without requiring them to know too much about all of the complex accounting and financial indicators surrounding the entity. More Info
The data published in Mustang Bio's official financial statements usually reflect Mustang Bio's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Mustang Bio. For example, before you start analyzing numbers published by Mustang accountants, it's critical to develop an understanding of what Mustang Bio's liquidity, profitability, and earnings quality are in the context of the Healthcare space in which it operates.
Please note, the presentation of Mustang Bio's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Mustang Bio's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Mustang Bio's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Mustang Bio. Please utilize our Beneish M Score to check the likelihood of Mustang Bio's management to manipulate its earnings.

Mustang Bio Company Summary

Mustang Bio competes with Regeneron Pharmaceuticals, and Vertex Pharmaceutic. Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. Mustang Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 102 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
CIK Number0001680048
RegionNorth America
Business Address377 Plantation Street,
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.mustangbio.com
Phone781 652 4500
CurrencyUSD - US Dollar
You should never invest in Mustang Bio without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Mustang Stock, because this is throwing your money away. Analyzing the key information contained in Mustang Bio's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.

Mustang Bio Key Financial Ratios

Generally speaking, Mustang Bio's financial ratios allow both analysts and investors to convert raw data from Mustang Bio's financial statements into concise, actionable information that can be used to evaluate the performance of Mustang Bio over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Mustang Bio reports annually and quarterly.

Mustang Bio Key Balance Sheet Accounts

201720182019202020212022 (projected)
Accounts Payable3.47 M5.38 M2.41 M3.88 M4.07 M3.34 M
Total Assets63.49 M42.75 M73.44 M109.9 M125.17 M135.05 M
Current Assets61.36 M35.12 M63.06 M99.53 M111.71 M120.52 M
Cash and Equivalents34.98 M16.47 M61.41 M97.8 M109.62 M118.27 M
Cash and Equivalents USD35.48 M16.97 M62.41 M98.8 M110.62 M92.16 M
Shareholders Equity59.83 M36.4 M51.65 M98.44 M112.4 M121.27 M
Shareholders Equity USD59.83 M36.4 M51.65 M98.44 M112.4 M96.11 M
Total Liabilities3.66 M6.36 M21.79 M11.46 M12.77 M10.53 M
Current Liabilities3.61 M5.62 M7.77 M9.52 M10.81 M11.67 M
Trade and Non Trade Payables3.66 M6.36 M6.26 M9.24 M10.47 M9.09 M
Accumulated Retained Earnings Deficit(48.41 M)(79.07 M)(125.46 M)(185.47 M)(251.84 M)(258.47 M)

Mustang Bio Key Income Statement Accounts

An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket. The other reason investors look at the income statement is to determine what Mustang Bio's earnings per share (EPS) will be in order to see if they want to buy more shares or not. For example, if a company earned $20 million in the last quarter and has 100,000 shares outstanding, its EPS is 20 cents. If you find that this number beats analysts' forecasts or is higher than it was from the same period last year, then you might want to buy more of this stock even though its price per share may not have changed.
201720182019202020212022 (projected)
Consolidated Income(31.29 M)(30.66 M)(46.39 M)(60.02 M)(66.37 M)(68.12 M)
Earning Before Interest and Taxes EBIT(31.28 M)(30.65 M)(44.62 M)(56.1 M)(66.36 M)(68.1 M)
Earning Before Interest and Taxes USD(31.28 M)(30.65 M)(44.62 M)(56.1 M)(66.36 M)(68.1 M)
Net Income(31.29 M)(30.66 M)(46.39 M)(60.02 M)(66.37 M)(71.61 M)
Net Income Common Stock(31.29 M)(30.66 M)(46.39 M)(60.02 M)(66.37 M)(68.12 M)
Net Income Common Stock USD(31.29 M)(30.66 M)(46.39 M)(60.02 M)(66.37 M)(68.12 M)
Operating Expenses31.79 M31.22 M45.88 M56.81 M66.72 M58.64 M
Operating Income(31.79 M)(31.22 M)(45.88 M)(56.81 M)(66.72 M)(68.48 M)
Research and Development Expense20.38 M24.46 M36.31 M47.3 M55.71 M47.91 M
Selling General and Administrative Expense11.41 M6.76 M9.57 M9.51 M11.02 M10.73 M
Weighted Average Shares25.25 M26.95 M36.06 M52.59 M87.89 M94.82 M
Weighted Average Shares Diluted25.25 M26.95 M36.06 M52.59 M87.89 M94.82 M

Mustang Bio Key Cash Accounts

Cash flow analysis captures how much money flows into and out of Mustang Bio. It measures of how well Mustang is doing because it can show the actual money that comes into and out of the company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money Mustang Bio brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money Mustang had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what Mustang Bio has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
201720182019202020212022 (projected)
Net Cash Flow or Change in Cash and Cash Equivalents7.98 M(18.51 M)45.44 M36.39 M11.81 M16.89 M
Issuance Purchase of Equity Shares50.3 M181 K54.14 M97.38 M72.23 M67.85 M
Net Cash Flow from Financing49.98 M181 K65.12 M78.12 M70.85 M76.44 M
Net Cash Flow from Operations(12.95 M)(19.24 M)(33.58 M)(37.32 M)(53.67 M)(55.08 M)

Mustang Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Mustang Bio's current stock value. Our valuation model uses many indicators to compare Mustang Bio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Mustang Bio competition to find correlations between indicators driving Mustang Bio's intrinsic value. More Info.
Mustang Bio is considered to be number one stock in shares owned by insiders category among related companies. It is regarded third in cash per share category among related companies fabricating about  0.05  of Cash per Share per Shares Owned by Insiders. The ratio of Shares Owned by Insiders to Cash per Share for Mustang Bio is roughly  20.22 . The value of Free Cash Flow is estimated to slide to about (59.2 M). Comparative valuation analysis is a catch-all model that can be used if you cannot value Mustang Bio by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Mustang Bio's Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Mustang Bio's earnings, one of the primary drivers of an investment's value.

Mustang Bio Systematic Risk

Mustang Bio's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Mustang Bio volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on Mustang Bio correlated with the market. If Beta is less than 0 Mustang Bio generally moves in the opposite direction as compared to the market. If Mustang Bio Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Mustang Bio is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Mustang Bio is generally in the same direction as the market. If Beta > 1 Mustang Bio moves generally in the same direction as, but more than the movement of the benchmark.
.

About Mustang Bio Financials

What exactly are Mustang Bio Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Mustang Bio's income statement, its balance sheet, and the statement of cash flows. Potential Mustang Bio investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Mustang Bio investors may use each financial statement separately, they are all related. The changes in Mustang Bio's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Mustang Bio's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Mustang Bio is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Mustang has grown by more than 25% over the last five years, then there is a good chance that it will continue growing at least by 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.

Mustang Bio November 27, 2022 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Mustang Bio help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Mustang Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of Mustang Bio based on widely used predictive technical indicators. In general, we focus on analyzing Mustang Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Mustang Bio's daily price indicators and compare them against related drivers.
Information Ratio(0.09)
Maximum Drawdown22.04
Value At Risk(7.69)
Potential Upside8.33
Additionally, see Correlation Analysis. You can also try Analyst Recommendations module to analyst recommendations and target price estimates broken down by several categories.

Complementary Tools for analysis

When running Mustang Bio price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Go
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
56.4 M
Return On Assets
(0.39) 
Return On Equity
(0.84) 
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine Mustang Bio value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.